Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Solitary Fibrous Tumors”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableEnded earlyNCT02613299
What this trial is testing

Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma

Who this might be right for
MesotheliomaSolitary Fibrous Tumor of the Pleura
Mayo Clinic 5
Testing effectiveness (Phase 2)UnknownNCT03946943
What this trial is testing

Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic Sarcoma

Who this might be right for
Soft Tissue SarcomasUndifferentiated Pleomorphic Sarcoma
Di Wu 25
Testing effectiveness (Phase 2)Study completedNCT03277924
What this trial is testing

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
Grupo Espanol de Investigacion en Sarcomas 197
Large-scale testing (Phase 3)Study completedNCT00423618
What this trial is testing

Randomised Trial of Volume of Post-operative Radiotherapy Given to Adult Patients With eXtremity Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Sheffield Teaching Hospitals NHS Foundation Trust 216
Testing effectiveness (Phase 2)Study completedNCT00025675
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Early research (Phase 1)Looking for participantsNCT06789172
What this trial is testing

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

Who this might be right for
Solid TumoursSarcomaHNSCC+9 more
Epkin 166
Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Testing effectiveness (Phase 2)Looking for participantsNCT07169344
What this trial is testing

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (Excluding GIST)Soft Tissue Sarcoma AdultSoft Tissue Sarcoma of the Trunk and Extremities+6 more
Oslo University Hospital 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT02399371
What this trial is testing

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Who this might be right for
Biphasic MesotheliomaEpithelioid MesotheliomaPeritoneal Malignant Mesothelioma+7 more
University of Chicago 65
Testing effectiveness (Phase 2)Study completedNCT00006357
What this trial is testing

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more
European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT00064220
What this trial is testing

Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Daiichi Sankyo
Large-scale testing (Phase 3)Study completedNCT00821860
What this trial is testing

Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant MesotheliomaMetastatic Cancer
Papworth Hospital NHS Foundation Trust 196
Testing effectiveness (Phase 2)Study completedNCT00006014
What this trial is testing

SU5416 in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Study completedNCT00492089
What this trial is testing

Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Meningioma+84 more
National Cancer Institute (NCI) 11
Early research (Phase 1)Study completedNCT00720174
What this trial is testing

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00243074
What this trial is testing

S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00227630
What this trial is testing

Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 59
Testing effectiveness (Phase 2)Study completedNCT00004183
What this trial is testing

Capecitabine in Treating Patients With Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 27
Testing effectiveness (Phase 2)Study completedNCT00041249
What this trial is testing

Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Gastrointestinal Stromal TumorSarcoma
European Organisation for Research and Treatment of Cancer - EORTC 64
Testing effectiveness (Phase 2)Study completedNCT00589784
What this trial is testing

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Who this might be right for
CNS CancerMeningiomaIntracranial Hemangiopericytoma+2 more
Memorial Sloan Kettering Cancer Center 50
Load More Results